Who invested in Roka Bioscience?
Roka Bioscience's investors include New Enterprise Associates, OrbiMed, TPG, Aisling Capital and Gen-Probe.
United States · Series E startup
Funding summaryUpdated 26 Oct 2026
$109Mraised across 4 rounds since 2011, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $17M sold, first sale Nov 2013
No investor was named in the report.
Reported by sec.govSEC filing: $25M sold, first sale Jun 2013
Reported by prnewswire.comSEC filing: $28M sold, first sale Sept 2009
Reported by finsmes.comSEC filing: $20M sold, first sale Sept 2009
From the SEC filings it signed: 2 on the team.
On the board, as filediDavid G. McGirrFred G. CohenJim G. BarretJonathan G. SilversteinMichael P. DoyleNicholas G. Valeriani
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Roka Bioscience's investors include New Enterprise Associates, OrbiMed, TPG, Aisling Capital and Gen-Probe.
Roka Bioscience has raised $109M across 4 rounds since 2011.
Roka Bioscience's most recent round was a Series E of $17M in Dec 2013.
Roka Bioscience's largest round on record is $48M (Series D), in Jan 2012.
Roka Bioscience's first round on record, in Jul 2011, was backed by New Enterprise Associates, OrbiMed and TPG and 1 others.
Roka Bioscience's latest named round is a Series E, in Dec 2013.
Roka Bioscience is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.